CD5 and B-cell chronic lymphocytic leukemia: Eμ‐TCL1 transgenic mice develop a lymphoproliferative disorder of CD5+ B cells starting at about 6 months of age and leading to a CLL‐like disease at the age of 10–12 months with initially oligoclonal and then monoclonal leukemic B‐cell populations.